Literature DB >> 9051330

Prevalence of migraine in Japan: a nationwide survey.

F Sakai1, H Igarashi.   

Abstract

This study presents the first nationwide survey of migraine in Japan. A representative sample of 4029 subjects aged 15 years or older was selected from the Japanese population according to the quota method. A combination of telephone interview and mailed questionnaire methods was used. Diagnosis of migraine was based on the International Headache Society (IHS) Classification. The overall prevalence of migraine in the past year was 8.4%; 5.8% was migraine without aura and 2.6% was migraine with aura. Significant correlation was found between the prevalence of migraine and such variables as gender, age and district of residence. Doctor attendance rate was very low and 69.4% with migraine had never consulted a physician for headache. Yet, 74.2% complained that migraine headache impaired their daily activity significantly. Only 11.6% were aware that their headache was migraine and 56.9% were using only the over-the-counter drugs. The study revealed a comparably high prevalence of migraine in the general population of Japan compared with other countries. A genetic factor was speculated as the cause of regional difference in migraine prevalence.

Entities:  

Mesh:

Year:  1997        PMID: 9051330     DOI: 10.1046/j.1468-2982.1997.1701015.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  67 in total

Review 1.  Evidence of Potential Mechanisms of Acupuncture from Functional MRI Data for Migraine Prophylaxis.

Authors:  Ching-Mao Chang; Chun-Pai Yang; Cheng-Chia Yang; Po-Hsuan Shih; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2021-05-26

2.  Headache at high school: clinical characteristics and impact.

Authors:  M C Tonini; F Frediani
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

3.  Metabolic syndrome and insulin resistance in migraine.

Authors:  Sanjeev K Bhoi; Jayantee Kalita; Usha K Misra
Journal:  J Headache Pain       Date:  2012-01-26       Impact factor: 7.277

4.  Neuroprotection by lomerizine, a prophylactic drug for migraine, against hydrogen peroxide-induced hippocampal neurotoxicity.

Authors:  Masakazu Ishii; Ryouta Iizuka; Yuji Kiuchi; Yasuo Mori; Shunichi Shimizu
Journal:  Mol Cell Biochem       Date:  2011-06-09       Impact factor: 3.396

5.  Predictive index for the onset of medication overuse headache in migraine patients.

Authors:  T Onaya; M Ishii; H Katoh; S Shimizu; H Kasai; M Kawamura; Y Kiuchi
Journal:  Neurol Sci       Date:  2013-01       Impact factor: 3.307

Review 6.  Epidemiology of migraine.

Authors:  S W Hamelsky; W F Stewart; R B Lipton
Journal:  Curr Pain Headache Rep       Date:  2001-04

7.  Effects of Flexibility in Coping with Chronic Headaches on Depressive Symptoms.

Authors:  Tsukasa Kato
Journal:  Int J Behav Med       Date:  2015-08

8.  The Effect of Paroxetine on the Reduction of Migraine Frequency is Independent of Its Anxiolytic Effect.

Authors:  Hyun-Jung Park; Soon-Tae Lee; Ji-Young Shim; Bomie Kim; Sun-Hee Hwang; Sook-Hee Kim; Jeong-Eun Park; Jong-Ha Park; Se-Hee Jung; Jin-Young Ahn; Kon Chu; Manho Kim
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

9.  Characteristics in patients with headache in an outpatient clinic in Japan.

Authors:  Toshikatsu Okumura; Sachie Tanno; Masumi Ohhira; Satoshi Tanno; Tsukasa Nozu
Journal:  Asia Pac Fam Med       Date:  2010-11-18

10.  Associations between headache and stress, alcohol drinking, exercise, sleep, and comorbid health conditions in a Japanese population.

Authors:  Masako Yokoyama; Tetsuji Yokoyama; Kazuo Funazu; Takeshi Yamashita; Shuji Kondo; Hiroshi Hosoai; Akira Yokoyama; Haruo Nakamura
Journal:  J Headache Pain       Date:  2009-03-27       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.